Ionis Pharmaceuticals Inc
- Last sale
- Nov 12, 2026 · -3.57%
- Market cap
- $4.55B
- 166.55M shares
- Filings
- 1,081
Q3 2026+33.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+53.8% FY25 yoy
- $4.55B
- —
- 4.7×
- 11.6×
- -13.55%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $943,711,000 | reported | |
| FY 2024 | 2024-12-31 | $705,138,000 | reported | |
| FY 2023 | 2023-12-31 | $787,647,000 | reported | |
| FY 2022 | 2022-12-31 | $587,367,000 | reported | |
| FY 2021 | 2021-12-31 | $810,456,000 | reported | |
| FY 2020 | 2020-12-31 | $729,264,000 | reported | |
| FY 2019 | 2019-12-31 | $1,122,599,000 | reported | |
| FY 2018 | 2018-12-31 | $599,674,000 | reported | |
| FY 2017 | 2017-12-31 | $514,179,000 revised | reported | |
| FY 2016 | 2016-12-31 | $372,776,000 revised | reported | |
| FY 2015 | 2015-12-31 | $283,703,000 | reported | |
| FY 2014 | 2014-12-31 | $214,161,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2022 | — | $0.00 | $0.00 | — | 142.95M sh | +0.9% | — |
| FY2021 | — | $0.00 | $0.00 | — | 141.69M sh | +0.6% | 0.0% |
| FY2020 | — | $90.55M | $90.55M | — | 140.86M sh | +1.2% | 11729.0% |
| FY2019 | — | $34.40M | $34.40M | — | 139.22M sh | +0.6% | 10.9% |
| FY2018 | — | $0.00 | $0.00 | — | 138.40M sh | +10.4% | 0.0% |
Segments
LineFY2025ShareChange
Ionis Operations$943.71M100%+33.8%
Akcea Therapeutics———
Ionis———
Total$943.71M
Pharmaceutical preparations
Ionis Pharmaceuticals Inc is the 37th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1BACADAcadia Pharmaceuticals Inc$1.1B11.9%36.5%$3.7BLEGNLegend Biotech Corp$1.0B64.0%28.8%$3.4BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9B
IONSIonis Pharmaceuticals Inc (this company)$943.7M33.8%40.4%$4.5B
ANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6BHRMYHarmony Biosciences Holdings, Inc.$868.5M21.5%18.3%$2.0BTLXTelix Pharmaceuticals Ltd$803.8M55.6%0.9%—COLLCollegium Pharmaceutical, Inc$780.6M23.6%8.1%$776.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR